Trials / Completed
CompletedNCT01167153
Effectiveness of Valsartan/Amlodipine (EXforge®) and Nifedipine treAtment coMparison in Treating Chinese Hypertensive Patients
A 12 Weeks, Multi-center, Open Label, Randomized, Active Drug Parallel Control Trial to Compare the Effectiveness of Valsartan/Amlodipine and Nifedipine in Treating Chinese Hypertensive Patients Not Respond to Mono Antihypertensive Treatment
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 564 (actual)
- Sponsor
- Novartis · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study was to compare the efficacy and safety of Valsartan/Amlodipine (EXforge®) with nifedipine, as well as vascular function index.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Valsartan/Amlodipine | Valsartan/Amlodipine 80/5mg single pill combination (SPC) |
| DRUG | Nifedipine | Nifedipine GITS (Gastro-Intestinal Therapeutic System ) 30 mg |
Timeline
- Start date
- 2010-05-01
- Primary completion
- 2011-04-01
- Completion
- 2011-04-01
- First posted
- 2010-07-22
- Last updated
- 2012-06-01
- Results posted
- 2012-06-01
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT01167153. Inclusion in this directory is not an endorsement.